• Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680; PubMed=28881731; PubMed=30551515).
  

PubMed=16107020
Mikhailova I.N., Lukashina M.I., Baryshnikov A.Y., Morozova L.F., Burova O.S., Palkina T.N., Kozlov A.M., Golubeva V.A., Cheremushkin E.A., Doroshenko M.B., Demidov L.V., Kiselev S.L., Larin S.S., Georgiev G.P.
Melanoma cell lines as the basis for antitumor vaccine preparation.
Vestn. Ross. Akad. Med. Nauk 2005:37-40(2005)

Patent=RU2390556
Mikhailova I.N., Baryshnikov A.Y., Demidov L.V., Kiselev S.L., Burova O.S., Morozova L.F., Vjacheslavovich S.I.
Human melanoma cell line mel Z used for making anti-tumour vaccines.
Patent number RU2390556, 27-May-2010

CLPUB00680
Mikhailova I.N., Baryshnikov A.Y., Morozova L.F., Burova O.S., Shubina I.Z., Kovalevsky D.A., Voronina E.S., Treshalina H.M., Lushnikova A.A., Tsyganova I.V., Mazurenko N.N.
Human skin melanoma cell lines collection.
(In) Management of malignant melanoma; pp.1-6; SM Group; Dover (2016)

PubMed=28881731; DOI=10.18632/oncotarget.17014
Emelyanova M., Ghukasyan L., Abramov I., Ryabaya O., Stepanova E.V., Kudryavtseva A., Sadritdinova A., Dzhumakova C., Belysheva T., Surzhikov S., Lyubchenko L., Zasedatelev A., Nasedkina T.
Detection of BRAF, NRAS, KIT, GNAQ, GNA11 and MAP2K1/2 mutations in Russian melanoma patients using LNA PCR clamp and biochip analysis.
Oncotarget 8:52304-52320(2017)

PubMed=30551515; DOI=10.1016/j.biopha.2018.11.109
Ryabaya O., Prokofieva A., Akasov R., Khochenkov D., Emelyanova M., Burov S., Markvicheva E., Inshakov A., Stepanova E.V.
Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells.
Biomed. Pharmacother. 109:2548-2560(2019)